ARTE CORPORATION

Company Profile

Transparency Guidelines

“Transparency Guideline for the Relation between Corporate Activities and Medical Institutions”

In accordance with the Transparency Guideline for the Relation between Corporate Activities and Medical Institutions (hereinafter referred to as the “Transparency Guidelines”), ARTE Corporation (hereinafter referred to as “the Company”) discloses funding information to medical institutions, etc. for the purpose of ensuring the transparency and credibility of relationships with the Company and gaining a broad understanding of how corporate activities are carried out with high ethical standards.

Disclosure Method Information for the previous year will be disclosed through the Company’s website.
Disclosure Timing We disclose information for the past five years at an appropriate and possible time in the following year.
Disclosure Range The range and content of the information to be disclosed conforms to the disclosure range stipulated in the Transparency Guidelines of the Japan Federation of Medical Devices Associations.
The Japan Federation of Medical Devices Associations homepage
Disclosure fiscal year 2022 There are no payment items.
2021 There are no payment items.
2020 There are no payment items.
2019 There are no payment items.
2018 There are no payment items.
pagetop